Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases

Growth Hormone and IGF Research

Volumn 9, Issue 4, 1999, Pages 241-253

  Gibson, Tara Leigh Beers ^a   Cohen, Pinchas ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MATTEL CHILDREN S HOSPITAL   (United States)

Author keywords

Cathepsin G; Elastase; IGF binding proteins; Insulin like growth factors

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; CATHEPSIN G; ELASTASE; PROTEINASE INHIBITOR; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6;

ARTICLE; CELL CULTURE; CELL MATURATION; CELL PROLIFERATION; FUNCTIONAL ASSESSMENT; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN DEGRADATION; REGULATORY MECHANISM; SEQUENCE ANALYSIS; WOUND HEALING;

EID: 0032724466     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1054/ghir.1999.0115     Document Type: Article

References (53)

1. Cohen P., Fielder P. J., Hasewaga Y., Frisch H., Guidice L. C., Rosenfeld R. G. Clinical aspects of insulin-like growth factor binding proteins. Acta Endocrinol. 124 (Suppl. 2):1991;74-85.
2. Jones J. L., Clemmons D. R. Insulin-like growth factors and their binding proteins: biological actions. Endocrin Rev. 16:1995;3-34.
3. Holly J. M. P., Claffrey D. C. P., Cwyfan-Hughes S. C., Frost V. J., Yateman M. E. Proteases acting on IGFBPs: their occurrence and physiological significance. Growth Reg. 3:1993;88-91.
4. Cohen P., Peehl D. M., Graves H. C. B., Rosenfeld R. G. Biological effects of prostate specific antigen (PSA) as an IGF binding protein-3 (IGFBP-3) protease. J Endocrinol. 142:1994;407-415.
5. Claussen M., Kubler B., Wendland M., Neifer K., Schmidt B., Zapf J., Braulke T. Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D. Endocrinology. 138:1997;3797-3803.
6. Conover C. A., DeLeon D. D. Acid-activated insulin-like growth factor binding protein-3 proteolysis in normal and transformed cells. J Biol Chem. 269:1994;7076-7080.
7. Rajah R., Bhala A., Nunn S. E., Peehl D. M., Cohen P. 7γ nerve growth factor is an insulin-like growth factor-binding protein protease. Endocrinology. 137:1996;2676-2682.
8. Booth B. A., Boes M., Bar R. S. IGFBP-3 proteolysis by plasmin, thrombin, serum: heparin binding, IGF binding, and structure of fragments. Am J Physiol. 271:1996;E465-E470.
9. Fowlkes J. L., Enghild J. J., Suzuki K., Nagase H. Matrix metalloproteinases degrade insulin-like growth factor binding protein-3 in dermal fibroblast cultures. J Biol Chem. 269:1994;25742-25746.
10. 4induces MMP-1 which functions as an IGF binding protein protease in airway smooth muscle cells. Am J Physiol. 271:1996;L1014-L1022.
11. Watorek W., Farley D., Salvesen G., Travis J. Neutrophil elastase and cathepsin G: structure, function, and biological control. Adv Exp Med Biol. 240:1988;23-31.
12. Sommerhoff C. P., Nadel J. A., Basbaum C. B., Caughey G. H. Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells. J Clin Invest. 85:1990;682-689.
13. Weiss S. J. Tissue destruction by neutrophils. N Engl J Med. 320:1989;365-376.
14. Mueller R. V., Spencer E. M., Sommer A., Maack C. A., Suh D., Hunt T. K. The role of IGF-I and IGFBP-3 in wound healing. Modern Concepts of Insulin-Like Growth Factors. 1991;185-192.
15. Lamson G., Giudice L. C., Rosenfeld R. G. A simple assay for proteolysis of IGFBP-3. J Clin Endocrinol Metab. 72:1991;1391-1393.
16. Schagger H., von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range of 1 to 100 kDa. Anal Biochem. 166:1987;368-379.
17. Boyum A. Isolation of mononuclear cells and granulocytes from human blood: isolation of mononuclear cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest. 21 (Suppl. 97):1963;77.
18. Conover C. A. Glycosylation of insulin-like growth factor binding protein-3 (IGFBP-3) is not required for potentiation of IGF-I action: evidence for processing of cell-bound IGFBP-3. Endocrinology. 129:1991;3259-3268.
19. Fowlkes J. L., Serra D. M. Characterization of glycosaminoglycan-binding domains present in insulin-like growth factor binding protein-3. J Biol Chem. 271:1996;14676-14679.
20. Fielder P. J., Rosenfeld R. G., Graves H. C. B., Grandbois K., Maack C. A., Sawamura S., Ogawa Y., Sommer A., Cohen P. Biochemical analysis of prostate specific antigen-proteolyzed insulin-like growh factor binding protein-3. Growth Reg. 4:1994;164-172.
21. Radulescu R. T. Nuclear localization signal in insulin-like growth factor-binding protein type 3. TIBS. 19:1994;278.
22. Synder R. A., Kaempfer C. E., Wintroub B. U. Chemistry of a human monocyte-derived cell line (U937): identification of the angiotensin I-converting activity as leukocyte cathepsin G. Blood. 65:1985;176.
23. Jones J. I., d'Ercole A. J., Camacho-Hubner C., Clemmons D. R. Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I. Proc Natl Acad Sci USA. 88:1991;7481-7485.
24. Fowlkes J. L., Serra D. M., Rosenberg C. K., Thrailkill K. M. Insulin-like growth factor (IGF)- binding protein-3 (IGFBP-3) functions as an IGF-reversible inhibitor of IGFBP-4 proteolysis. J Biol Chem. 270:1995;27481-27488.
25. Cohen P., Graves H. C. B., Peehl D. M., Kamarei M., Giudice L., Rosenfeld R. G. Prostate specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab. 75:1992;1046-1053.
26. Senior R. M., Campbell E. J. Cathepsin G in human mononuclear phagocytes: comparisons between monocytes and U937 monocyte-like cells. J Immunol. 132:1984;2547-2551.
27. Reilly C. F., Travis J. The degradation of human lung elastin by neutrophil proteinases. Biochim Biophys Acta. 621:1980;147-157.
28. McDonald J. A., Kelley D. G. Degradation of fibronectin by human leukocyte elastase: release of biologically active fragments. J Biol Chem. 255:1980;8848-8858.
29. Vartio T., Seppa H., Vaheri A. Susceptibility of soluble and matrix fibronectins to degradation by tissue proteinases, mast cell chymase, and cathepsin G. J Biol Chem. 256:1981;471-477.
30. Keiser H., Greenwald R. A., Feinstein G., Janoff A. Degradation of cartilage proteoglycan by human leukocyte granule neutral proteases - a model of joint injury. II. degradation of isolated bovine nasal cartilage proteoglycan. J Clin Invest. 57:1976;625-632.
31. Mainardi C. L., Dixit S. N., Kang A. H. Degradation of type IV (basement membrane) collagen by a proteinase isolated from human polymorphonuclear leukocyte granules. J Biol Chem. 255:1980;5435-5441.
32. Gadek J. E., Fells G. A., Wright D. G., Crystal R. G. Human neutrophil elastase functions as a type III collagen "collagenase" Biochem Biophys Res Commun. 95:1980;1815-1822.
33. Mainardi C. L., Hasty D. L., Seyer J. M., Kang A. H. Specific cleavage of human type III collagen by human polymorphonuclear leukocyte elastase. J Biol Chem. 255:1980;12006-12010.
34. Pipoly D. J., Crouch E. C. Degradation of native type IV procollagen by human neutrophil elastase. Implications for leukocyte-mediated degradation of basement membranes. Biochemistry. 26:1987;5748-5754.
35. Taylor J. C., Crawford I. P., Hugli T. E. Limited degradation of third component (C3) of human complement by human leukocyte elastase (HLE): partial characterization of C3 fragments. Biochemistry. 16:1977;3390-3396.
36. Orr F. W., Varani J., Kreutzer D. L., Senior R. M., Ward P. A. Digestion of the fifth component of complement by leukocyte enzymes: sequential generation of chemotactic activities for leukocytes and for tumor cells. Am J Pathol. 94:1979;75-83.
37. Venge P., Olsson I. Cationic proteins of human granulocytes: VI. Effects on the complement system and mediation of chemotactic activity. J Immunol. 115:1975;1505-1508.
38. Okada Y., Nakanishi I. Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 (gelatinase) by human neutrophil elastase and cathepsin G. FEBS. 249:1989;353-356.
39. Baici A., Knopfel M., Fehr K. Cathepsin G from human polymorphonuclear leukocytes cleaves human IgM. Mol Immunol. 19:1982;719-727.
40. Solomon A., Gramse M., Havemann K. Proteolytic cleavage of human IgG molecules by neutral proteases of polymorphonuclear leukocytes. Eur J Immunol. 8:1978;782-785.
41. Reilly C. F., Tewksbury D. A., Schechter N. M., Travis J. Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. J Biol Chem. 257:1982;8619-8622.
42. Tonnesen M. G., Klempner M. S., Austen K. F., Wintroub B. U. Identification of a neutrophil angiotensin II generating protease as cathepsin G. J Clin Invest. 69:1982;25-30.
43. Klickstein L. B., Kaempfer C. E., Wintroub B. U. The granulocyte-angiotensin system: angiotensin I-converting activity of cathepsin G. J Biol Chem. 257:1982;15042-15046.
44. Boudier C., Holle C., Bieth J. G. Stimulation of the elastolytic activity of leukocyte elastase by leukocyte cathepsin G. J Biol Chem. 256:1981;10256-10258.
45. Boudier C., Laurent P., Bieth J. G. Leukoproteinases and pulmonary emphysema: cathepsin G and other chymotrypsin-like proteinases enhance the elastolytic activity of elastase in lung elastin. Adv Exp Med Biol. 167:1984;313-317.
46. Janoff A. Elastases and emphysema: current assessment of the protease-antiprotease hypothesis. Am Rev Respir Dis. 132:1985;417-433.
47. Janoff A. Elastase in tissue injury. Annu Rev Med. 36:1985;207-216.
48. Saklatvala J., Barrett A. J. Identification of proteinases in rheumatoid synovium: detection of leukocyte elastase, cathepsin G, and another serine proteinase. Biochim Biophys Acta. 615:1980;167-177.
49. Weiland J. E., Davis W. B., Holter J. F., Mohammed J. R., Dorinsky P. M., Gadek J. E. Lung neutrophils in the adult respiratory distress syndrome: clinical and pathophysiologic significance. Annu Rev Respir Dis. 133:1986;218-225.
50. Chester J. F., Ross J. S., Malt R. A., Weitzman S. A. Acute colitis produced by chemotactic peptides in rats and mice. Am J Pathol. 121:1985;284-290.
51. Johnson R. J., Couser W. G., Alpers C. E., Vissers M., Schulze M., Klebanoff S. J. The human neutrophil serine proteinases, elastase and cathepsin G, can mediate glomerular injury in vivo. J Exp Med. 168:1988;1169-1174.
52. Malech H. L., Gallin J. I. Neutrophils in human diseases. N Engl J Med. 317:1987;687-694.
53. Henson P. M., Johnston R. B. Jr. Tissue injury in inflammation: oxidants proteinases and cationic proteins. J Clin Invest. 79:1987;669-674.